CompletedPhase 2NCT00370825

Combination Chemotherapy for the Treatment of Indian Kala-Azar

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Banaras Hindu University
Principal Investigator
Shyam Sundar, MD
Banaras Hindu University
Intervention
Combination therapy with AmBisome and miltefosine(drug)
Enrollment
200 target
Eligibility
12-65 years · All sexes
Timeline
2006

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00370825 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis

← Back to all trials